The Association between Adiponectin Single Nucleotide Polymorphisms and Side Effects of Isotretinoin in Acne Patients

Background Acne is a common condition of pilosebaceous follicle especially among young. Clinically, the most used medication in the treatment of moderate to severe acne is oral isotretinoin. However, interindividual variability in therapeutic response to isotretinoin and many side effects such as musculoskeletal pain, headache, and alteration in lipid profile can be seen with this treatment. Aim In this study, the effect of genetic polymorphisms, rs2241766 and rs1501299, of the adiponectin gene was investigated in relation to the side effects of isotretinoin-treated young adult acne patients (n = 230). Methods Several biochemical parameters were measured at baseline and after treatments with isotretinoin. The ADIPOQ gene SNPs, rs2241766 and rs1501299, were genotyped in 230 patients. Results Alterations in lipid profile with a significant increase of ALT (P=0.007) were detected after isotretinoin treatment. Moreover, percentage change in HDL following isotretinoin treatment was significantly associated with rs1501299 (P=0.008). On the other hand, no associations between examined SNPs and side effects of isotretinoin and other lipid parameters (total cholesterol, LDL, and triglycerides) or liver function enzymes (ALT and AST) were detected. Conclusions Current findings showed that rs1501299 of the ADIPOQ gene might be associated with changes in HDL level in acne patients following treatment with isotretinoin.

[1]  D. D. de Luis,et al.  The effect of single-nucleotide polymorphisms at the ADIPOQ gene locus rs1501299 on metabolic parameters after 9 mo of a high-protein/low-carbohydrate versus a standard hypocaloric diet. , 2019, Nutrition.

[2]  B. Yalçın,et al.  Minimize the regular laboratory monitoring during the systemic isotretinoin treatment: data of 704 patients with acne vulgaris , 2019, The Journal of dermatological treatment.

[3]  Justin W Marson,et al.  An Overview of Acne Therapy, Part 2: Hormonal Therapy and Isotretinoin. , 2019, Dermatologic clinics.

[4]  Alessandra Suuberg.  Psychiatric and Developmental Effects of Isotretinoin (Retinoid) Treatment for Acne Vulgaris , 2019, Current therapeutic research, clinical and experimental.

[5]  M. El-Hamd,et al.  Vitamin D levels in acne vulgaris patients treated with oral isotretinoin , 2019, Journal of cosmetic dermatology.

[6]  A. Aksakal,et al.  The effect of isotretinoin on insulin resistance and adipocytokine levels in acne vulgaris patients , 2019, Turkish journal of medical sciences.

[7]  Xingyu Zhang,et al.  Daily Intake of Soft Drinks and Moderate‐to‐Severe Acne Vulgaris in Chinese Adolescents , 2019, The Journal of pediatrics.

[8]  G. Chrousos,et al.  A novel cognitive stress management technique for acne vulgaris: a short report of a pilot experimental study , 2018, International journal of dermatology.

[9]  M. Ramadan,et al.  Single Nucleotide Polymorphism in Adiponectin Gene and Risk of Pancreatic Adenocarcinoma , 2019, Asian Pacific journal of cancer prevention : APJCP.

[10]  Fei Han.  Acne Vulgaris. , 2019, The New England journal of medicine.

[11]  A. Tremblay,et al.  Variants in APOA5 and ADIPOQ Moderate Improvements in Metabolic Syndrome during a One-Year Lifestyle Intervention , 2018, Lifestyle Genomics.

[12]  Hao Jiang,et al.  Common Pathogenesis of Acne Vulgaris and Atherosclerosis , 2018, Inflammation.

[13]  Juhyun Song,et al.  T allele at ADIPOQ rs1501299 G/T polymorphism is more susceptible to the influence of circulating adiponectin on arterial stiffness in nondiabetic men , 2018, Diabetology & Metabolic Syndrome.

[14]  K. Alzoubi,et al.  Association between leptin gene rs7799039 polymorphism and lipid profile changes induced by isotretinoin treatment in acne patients , 2018, Therapeutics and clinical risk management.

[15]  Lakhdar Ghazouani,et al.  Contribution of adiponectin polymorphisms to the risk of coronary artery disease in a North‐African Tunisian population , 2018, Journal of clinical laboratory analysis.

[16]  M. Hussain,et al.  Adiponectin gene polymorphisms as a predictor for development of type 2 diabetes mellitus in Iraqi population. , 2018, Gene.

[17]  S. Orlow,et al.  Clinical evidence for washing and cleansers in acne vulgaris: a systematic review* , 2018, The Journal of dermatological treatment.

[18]  O. Khabour,et al.  The Relationship of adiponectin level and ADIPOQ gene variants with BMI among young adult women , 2018, Dermato-endocrinology.

[19]  Somenath Sarkar,et al.  Low-dose isotretinoin therapy and blood lipid abnormality: A case series with sixty patients , 2018, Journal of family medicine and primary care.

[20]  D. Aksoy,et al.  Suppressed Adiponectin Levels and Increased Adiponectin Response to Oral Glucose Load in Lean Women with Severe Acne Normalizes after Isotretinoin Treatment , 2017, Dermatology.

[21]  Wei Wang,et al.  An Updated Systematic Review and Meta-analysis of Association Between Adiponectin Gene Polymorphisms and Coronary Artery Disease. , 2017, Omics : a journal of integrative biology.

[22]  Q. Ma,et al.  Associations between two common single nucleotide polymorphisms (rs2241766 and rs1501299) of ADIPOQ gene and coronary artery disease in type 2 diabetic patients: a systematic review and meta-analysis , 2017, Oncotarget.

[23]  Q. Ma,et al.  Associations between polymorphisms of the ADIPOQ gene and hypertension risk: a systematic and meta-analysis , 2017, Scientific Reports.

[24]  S. Stein,et al.  Clinical Guidelines for Management of Acne Vulgaris-Reply. , 2017, JAMA.

[25]  D. D. de Luis,et al.  rs1501299 Polymorphism in the Adiponectin Gene and Their Association with Total Adiponectin Levels, Insulin Resistance and Metabolic Syndrome in Obese Subjects , 2016, Annals of Nutrition and Metabolism.

[26]  C. Ergin,et al.  Effects of isotretinoin on body mass index, serum adiponectin, leptin, and ghrelin levels in acne vulgaris patients , 2016, Postepy dermatologii i alergologii.

[27]  H. Ahmad,et al.  Analysis of clinical efficacy, side effects, and laboratory changes among patients with acne vulgaris receiving single versus twice daily dose of oral isotretinoin , 2015, Dermatologic therapy.

[28]  D. Ertuğrul,et al.  The Effect of Isotretinoin on Retinol-Binding Protein 4, Leptin, Adiponectin and Insulin Resistance in Acne Vulgaris Patients , 2015, Dermatology.

[29]  Y. Çayır,et al.  Effects of oral isotretinoin on lipids and liver enzymes in acne patients. , 2014, Cutis.

[30]  Yuhua Shi,et al.  [Family-based analysis of the adiponectin gene polymorphisms and polycystic ovary syndrome]. , 2014, Zhonghua fu chan ke za zhi.

[31]  M. Al-Jarrah,et al.  Association of adiponectin protein and ADIPOQ gene variants with lumbar disc degeneration , 2014, Experimental and therapeutic medicine.

[32]  Jing-jing Wu,et al.  Association of Adiponectin Gene (ADIPOQ) rs2241766 Polymorphism with Obesity in Adults: A Meta-Analysis , 2014, PloS one.

[33]  D. Kiortsis,et al.  Adiponectin and lipoprotein metabolism , 2013, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[34]  G. Fantuzzi.  Adiponectin in inflammatory and immune-mediated diseases. , 2013, Cytokine.

[35]  H. Möller,et al.  Psychosis during treatment with isotretinoin , 2013, Therapeutic advances in psychopharmacology.

[36]  N. Mhaidat,et al.  The effect of genetic polymorphisms of RARA gene on the adverse effects profile of isotretinoin-treated acne patients. , 2013, International journal of clinical pharmacology and therapeutics.

[37]  Maryam H. Al-Zahrani,et al.  The adiponectin gene, ADIPOQ, and genetic susceptibility to colon cancer. , 2012, Oncology letters.

[38]  Wei Zhang,et al.  Adiponectin Stimulates Proliferation of Adult Hippocampal Neural Stem/Progenitor Cells through Activation of p38 Mitogen-activated Protein Kinase (p38MAPK)/Glycogen Synthase Kinase 3β (GSK-3β)/β-Catenin Signaling Cascade* , 2011, The Journal of Biological Chemistry.

[39]  A. Zaenglein,et al.  Isotretinoin increases skin‐surface levels of neutrophil gelatinase‐associated lipocalin in patients treated for severe acne , 2011, The British journal of dermatology.

[40]  B. Venkatesh,et al.  Clinical review: Adiponectin biology and its role in inflammation and critical illness , 2011, Critical care.

[41]  Bin Zhou,et al.  Analysis of Adiponectin Gene Polymorphisms in Chinese Population with Systemic Lupus Erythematosus , 2010, Journal of biomedicine & biotechnology.

[42]  S. Mousa,et al.  Current status and future directions in lipid management: emphasizing low-density lipoproteins, high-density lipoproteins, and triglycerides as targets for therapy , 2010, Vascular health and risk management.

[43]  David M. Evans,et al.  Clear detection of ADIPOQ locus as the major gene for plasma adiponectin: results of genome-wide association analyses including 4659 European individuals. , 2010, Atherosclerosis.

[44]  A. Layton.  The use of isotretinoin in acne , 2009, Dermato-endocrinology.

[45]  E. Alpsoy,et al.  Treatment of acne with intermittent and conventional isotretinoin: a randomized, controlled multicenter study , 2007, Archives of Dermatological Research.

[46]  M. Agarwal,et al.  Variations in lipid and lipoprotein levels during isotretinoin treatment for acne vulgaris with special emphasis on HDL‐cholesterol , 1997, International journal of dermatology.

[47]  M Toscano,et al.  [Acne vulgaris]. , 1992, Canadian family physician Medecin de famille canadien.